ES8401977A1 - Procedimiento para preparar nuevos compuestos de cefem. - Google Patents

Procedimiento para preparar nuevos compuestos de cefem.

Info

Publication number
ES8401977A1
ES8401977A1 ES518227A ES518227A ES8401977A1 ES 8401977 A1 ES8401977 A1 ES 8401977A1 ES 518227 A ES518227 A ES 518227A ES 518227 A ES518227 A ES 518227A ES 8401977 A1 ES8401977 A1 ES 8401977A1
Authority
ES
Spain
Prior art keywords
carboxi
procedure
protected
prepare new
cefem compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES518227A
Other languages
English (en)
Other versions
ES518227A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES518227A0 publication Critical patent/ES518227A0/es
Publication of ES8401977A1 publication Critical patent/ES8401977A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Paper (AREA)
  • Reinforcement Elements For Buildings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Soil Working Implements (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE CEFEM, DE FORMULA GENERAL (I), EN LA QUE R ES CARBOXI O CARBOXI PROTEGIDO; R ES ALQUILO INFERIOR-TIO; R ES CARBOXI O CARBOXI PROTEGIDO; Y R ES AMINO, AMINO PROTEGIDO O ALQUILAMINO INFERIOR O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II), EN LA QUE R, R Y R TIENEN CADA UNO EL SIGNIFICADO YA INDICADO; Y X1 ES HALOGENO, O UNA SAL DEL MISMO, CON UN COMPUESTO DE FORMULA (III), EN LA QUE R TIENE EL SIGNIFICADO YA INDICADO.DE APLICACION EN FARMACIAPOR SU ACTIVIDAD ANTIMICROBIANA.
ES518227A 1981-02-02 1982-12-15 Procedimiento para preparar nuevos compuestos de cefem. Expired ES8401977A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8103081 1981-02-02
GB8108884 1981-03-20

Publications (2)

Publication Number Publication Date
ES518227A0 ES518227A0 (es) 1984-01-01
ES8401977A1 true ES8401977A1 (es) 1984-01-01

Family

ID=26278300

Family Applications (2)

Application Number Title Priority Date Filing Date
ES509242A Expired ES8304994A1 (es) 1981-02-02 1982-02-01 "procedimiento para preparar nuevos compuestos de cefem".
ES518227A Expired ES8401977A1 (es) 1981-02-02 1982-12-15 Procedimiento para preparar nuevos compuestos de cefem.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES509242A Expired ES8304994A1 (es) 1981-02-02 1982-02-01 "procedimiento para preparar nuevos compuestos de cefem".

Country Status (13)

Country Link
US (1) US4452851A (es)
EP (2) EP0191507B1 (es)
KR (1) KR880001119B1 (es)
AT (2) ATE37882T1 (es)
AU (1) AU7994082A (es)
CA (1) CA1199320A (es)
DE (2) DE3280172D1 (es)
DK (1) DK43882A (es)
ES (2) ES8304994A1 (es)
FI (1) FI820295L (es)
GR (1) GR76342B (es)
NO (1) NO820292L (es)
PT (1) PT74355B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482587A1 (fr) * 1980-05-14 1981-11-20 Poudres & Explosifs Ste Nale Procede de synthese de chloroformiates a-chlores et nouveaux chloroformiates a-chlores
EP0055465B1 (en) * 1980-12-31 1989-08-23 Fujisawa Pharmaceutical Co., Ltd. 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
JPS5910591A (ja) * 1982-07-09 1984-01-20 Meiji Seika Kaisha Ltd １−オキサデチアセフアロスポリン化合物及びそれを含む抗菌剤
JPS5984890A (ja) * 1982-11-05 1984-05-16 Hisayasu Ishimaru 経口用セフアロスポリン化合物
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
FR2550200B1 (fr) * 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
FR2551058B1 (fr) * 1983-08-26 1986-09-26 Poudres & Explosifs Ste Nale Procede de preparation de chloroformiates a-chlores
GB8406231D0 (en) * 1984-03-09 1984-04-11 Fujisawa Pharmaceutical Co Cephem compounds
JPS60224693A (ja) * 1984-04-20 1985-11-09 Takeda Chem Ind Ltd セフアロスポリンエステル誘導体
US4761409A (en) * 1984-08-16 1988-08-02 Sumitomo Pharmaceuticals Company, Limited Cephem derivatives
US4812562A (en) * 1985-07-25 1989-03-14 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4699981A (en) * 1985-08-12 1987-10-13 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
DE3809845A1 (de) * 1988-03-24 1989-10-12 Hoechst Ag Verfahren zur herstellung von 4-halo-3-oxo-2-alkoxyiminobuttersaeureestern
JPH0393762A (ja) * 1989-09-04 1991-04-18 Wako Pure Chem Ind Ltd ４‐ハロゲノ‐２‐アルコキシイミノ‐３‐オキソ脂肪酸の製造方法
GB9519883D0 (en) * 1995-09-29 1995-11-29 Fujisawa Pharmaceutical Co New cephem compounds
US6733116B1 (en) 1998-10-16 2004-05-11 Silverbrook Research Pty Ltd Ink jet printer with print roll and printhead assemblies
US20050059820A1 (en) * 2003-09-17 2005-03-17 Debashish Datta Method for manufacture of ceftriaxone sodium
US20050059821A1 (en) * 2003-09-17 2005-03-17 Debashish Datta Method for manufacture of ceftriaxone sodium
SI3616695T1 (sl) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozan/tazobaktam za zdravljenje intrapulmonalnih okužb
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
UA121298C2 (uk) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. Антибіотична композиція на основі цефтолозану і тазобактаму
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN109232305A (zh) * 2018-08-28 2019-01-18 山东金城柯瑞化学有限公司 Cmoba的制备方法
CN111592471B (zh) * 2020-06-12 2023-03-21 济南大学 一种溴化反应合成头孢活性酯中间体的方法
CN117510367B (zh) * 2024-01-04 2024-03-12 山东金城柯瑞化学有限公司 头孢克肟侧链开环酸的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
CH605997A5 (es) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
US4150156A (en) * 1975-11-21 1979-04-17 Merck & Co., Inc. 7-(Substituted methyl)-3-(substituted thio)-cephalosporins, derivatives and pharmaceutical compositions containing them
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
FR2384779A1 (fr) * 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-chloro ou 3-methoxy 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
FR2418233A2 (fr) * 1978-02-22 1979-09-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkylthio ou 3-acylamino 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4374834A (en) * 1978-04-07 1983-02-22 Roussel Uclaf Novel compounds
BE870067A (fr) * 1978-09-04 1979-02-28 Ciba Geigy Derives d'oximes pour la protection des cultures
FR2448543A1 (fr) * 1979-02-09 1980-09-05 Roussel Uclaf Nouvelles oximes o-substituees par un radical comportant un ammonium quaternaire et derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
CH648038A5 (de) * 1981-01-19 1985-02-28 Sandoz Ag 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung.

Also Published As

Publication number Publication date
EP0057422A2 (en) 1982-08-11
ES509242A0 (es) 1983-03-16
ATE52766T1 (de) 1990-06-15
DE3280172D1 (de) 1990-06-21
EP0191507A2 (en) 1986-08-20
KR830009118A (ko) 1983-12-17
EP0057422B1 (en) 1988-10-12
EP0191507A3 (en) 1986-10-29
ATE37882T1 (de) 1988-10-15
PT74355A (en) 1982-02-01
ES518227A0 (es) 1984-01-01
US4452851A (en) 1984-06-05
ES8304994A1 (es) 1983-03-16
EP0057422A3 (en) 1983-11-23
CA1199320A (en) 1986-01-14
DK43882A (da) 1982-08-03
FI820295A7 (fi) 1982-08-03
FI820295L (fi) 1982-08-03
NO820292L (no) 1982-08-03
AU7994082A (en) 1982-08-12
DE3279103D1 (en) 1988-11-17
KR880001119B1 (ko) 1988-06-30
EP0191507B1 (en) 1990-05-16
GR76342B (es) 1984-08-06
PT74355B (en) 1983-08-08

Similar Documents

Publication Publication Date Title
ES8401977A1 (es) Procedimiento para preparar nuevos compuestos de cefem.
ES8206440A1 (es) Un procedimiento para la preparacion del enantiomero (-) de la n-metil-3-(2metilfenoxi)-3-fenilpropilamina.
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
DK577584D0 (da) Substituerede 2-pyridylmethyl-thio og -sulfinylbenzimidazoler til brug som gastriske antisekretoriske midler
ES2018177B3 (es) Procedimiento para el agotamiento de soluciones acuosas de aminas.
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
GT198400140A (es) Nuevos derivados de pirazol que poseen actividad herbicida.
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK398483D0 (da) Substiuerede tert.butanolderivater, fremgangsmader til fremstilling deraf samt antimykotiske midler indeholdende disse forbindelser
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
NO864972D0 (no) Plantebeskyttelsesmidler.
ES8305316A1 (es) Un procedimiento para la preparacion de guanidinas.
ES368401A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
ES8505367A1 (es) Procedimiento para la preparacion de derivados de acridanona
ES2063014T3 (es) Derivados de 2-oxa-isocefemo, composiciones que los contienen y procedimientos de preparacion.
ES8506710A1 (es) Procedimiento para la obtencion de teofilin-7-acetato de ambroxol
SU1825499A3 (ru) Гидрохлорид n-(2-адамантил)гексаметиленимина, обладающий антикаталептической активностью
DK140499C (da) N,n'-bis-((1-formamido-2,2,2-trichlor)ethyl)-piperazin til anvendelse som fungicid
ES8402582A1 (es) Un procedimiento para la preparacion de benzodiacepinas.
SU1075674A1 (ru) 2,3,2,3-Тетрагидро-3,3-тетрацианметилен-5,5-бис-as-триазин, обладающий противовоспалительной и анальгетической активностью

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000601